Market Overview

AnaptysBio (NASDAQ: ANAB)

37.10 +0.06 (0.16%)

Analyst Ratings

DateResearch FirmActionCurrentPT
10/03/19Credit SuisseMaintainsNeutral48.0
8/09/19Credit SuisseMaintainsNeutral75.0
6/24/19SunTrust Robinson HumphreyMaintainsBuy93.0
6/21/19Credit SuisseDowngradesNeutral
2/22/19GuggenheimInitiates Coverage OnBuy
12/20/18H.C. WainwrightInitiates Coverage OnBuy126.0
11/21/18JP MorganInitiates Coverage OnOverweight115.0
9/27/18Credit SuisseMaintainsOutperform147.0
9/14/18Stifel NicolausReinstatesBuy127.0
8/28/18Cantor FitzgeraldInitiates Coverage OnOverweight124.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter